GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Bank of Japan boosts rates, continuing an unwinding carry trade
December 22, 2025 / www.canadianminingreport.com
Gold stocks outperform equity market slide
December 22, 2025 / www.canadianminingreport.com
Silver inventories rebound in UK, output from major producers rises
December 15, 2025 / www.canadianminingreport.com
Silver's three-month outperformance continues
December 15, 2025 / www.canadianminingreport.com
Silver & Copper Supply Distortions Continue
December 08, 2025 / www.canadianminingreport.com